Searchable abstracts of presentations at key conferences in endocrinology

ea0065op6.2 | Neuroendocrinology, Pituitary and Neoplasia | SFEBES2019

Transcriptomic analyses reveal deregulation of focal adhesion pathway in Aip KO mice and AIP mutation positive human tumours

Bollington Mark , Mistry Anisha , Solomou Antonia , Barry Sayka , Begalli Federica , Vignola Maria , Lim Chung Thong , Herincs Maria , Roncaroli Federico , Gaston-Massuet Carles , Korbonits Marta

Introduction: AIP mutations are responsible for 15-30% of cases of familial isolated pituitary adenomas. The pathophysiology that drives this AIP-related pituitary tumorigenesis is not fully understood. We developed a pituitary-specific Aip knockout (KO) mouse model, which mostly recapitulates the human phenotype.Aims: To performed comparative gene expression analysis of Aip-KO mouse pituitary tumours and AIP mutation positive ...

ea0099p513 | Pituitary and Neuroendocrinology | ECE2024

Novel mutations causing pachydermoperiostosis - hormonal and phenotypic alterations

Stelmachowska-Banaś Maria , Barry Sayka , Angurala Ishita , Rice Tom , Magid Kesson , Carreira Ana , Rai Ashutosh , Evans Amy , Bollington Mark , Kaur Vaishali , Alina Silaghi Cristina , McGregor Alan , Mandisodza Kudakwashe , Sahoo Jayaprakash , Gupta Rahul , Behera Kishore , Roy Ayan , Carr Ian , Loughrey Paul , Dutta Pinaki , Korbonits Marta

Background: Pachydermoperiostosis (primary hypertrophic osteoarthropathy, PHO) is a rare genetic disease characterised by clinical signs and symptoms which may overlap with acromegaly (pachydermia, hyperhidrosis and enlargement of hands and feet). In the majority of cases, the disease is due to biallelic loss-of-function variants in either of two genes, SLCO2A1 and HPGD playing an important role in prostaglandin metabolism. Although PHO patients are often ref...